...
首页> 外文期刊>World Journal of Surgical Oncology >The value of chest CT for prediction of breast tumor size: comparison with pathology measurement
【24h】

The value of chest CT for prediction of breast tumor size: comparison with pathology measurement

机译:胸部CT预测乳腺肿瘤大小的价值:与病理测量比较

获取原文
           

摘要

Background Little information is available on the use of chest computed tomography (CT) to predict breast tumor size in breast cancer, despite the fact that chest CT examinations are being increasingly used. The purpose of this study was to evaluate the value of chest CT for predicting breast tumor size using pathology measurements as reference standards. Methods Tumor sizes (defined as greatest diameter) were retrospectively measured on the preoperative chest CT images of 285 patients with surgically proven unifocal, invasive breast carcinoma. Greatest tumor diameters as determined by chest CT and pathologic examinations were compared by linear regression and Spearman’s rho correlation analysis. Concordance between CT and pathology results was defined as a diameter difference of Results CT and pathology measured diameters were found to be linearly related (size at pathology = 1.086 × CT determined tumor size - 1.141; Spearman’s rho correlation coefficient = 0.84, P Conclusions Tumor size by chest CT is well correlated with pathology determined tumor size in breast cancer patients, and the diameters of the majority of tumors by chest CT and pathology differed by
机译:背景技术尽管越来越多地使用胸部CT检查,但仍然可以使用胸部计算断层摄影(CT)来预测乳腺癌中的乳腺肿瘤大小。本研究的目的是评估使用病理测量作为参考标准的病理学测量来预测乳腺肿瘤大小的胸部CT的值。方法回顾性测量肿瘤尺寸(定义为最大直径),在术前胸部CT图像的术前胸部CT图像,手术证明小型侵袭性乳腺癌的术前胸部CT图像。通过线性回归和Spearman的Rho相关分析比较了胸CT和病理检查确定的最大肿瘤直径。 CT和病理结果之间的一致性被定义为结果的直径差异,发现测量的直径被发现线性相关(病理学尺寸= 1.086×CT确定肿瘤大小 - 1.141; Spearman的RHO相关系数= 0.84,P结论肿瘤大小通过胸部CT与病理学确定肿瘤患者的病理学良好相关,胸部CT和病理到大多数肿瘤的直径

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号